BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Deng L, Huang Y, Li L, Chen H, Su J. Serum miR-29a/b expression in gestational diabetes mellitus and its influence on prognosis evaluation. J Int Med Res 2020;48:300060520954763. [PMID: 32993411 DOI: 10.1177/0300060520954763] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Valencia-Ortega J, Saucedo R, Sánchez-Rodríguez MA, Cruz-Durán JG, Martínez EGR. Epigenetic Alterations Related to Gestational Diabetes Mellitus. Int J Mol Sci 2021;22:9462. [PMID: 34502370 DOI: 10.3390/ijms22179462] [Reference Citation Analysis]
2 Cione E, Cannataro R, Gallelli L, De Sarro G, Caroleo MC. Exosome microRNAs in Metabolic Syndrome as Tools for the Early Monitoring of Diabetes and Possible Therapeutic Options. Pharmaceuticals (Basel) 2021;14:1257. [PMID: 34959658 DOI: 10.3390/ph14121257] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
3 He X, Kuang G, Wu Y, Ou C. Emerging roles of exosomal miRNAs in diabetes mellitus. Clin Transl Med 2021;11:e468. [PMID: 34185424 DOI: 10.1002/ctm2.468] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
4 Zhang TN, Wang W, Huang XM, Gao SY. Non-Coding RNAs and Extracellular Vehicles: Their Role in the Pathogenesis of Gestational Diabetes Mellitus. Front Endocrinol (Lausanne) 2021;12:664287. [PMID: 34093439 DOI: 10.3389/fendo.2021.664287] [Reference Citation Analysis]
5 Zheng H, Yu Z, Wang H, Liu H, Chen X. MicroRNA-195-5p facilitates endothelial dysfunction by inhibiting vascular endothelial growth factor A in gestational diabetes mellitus. Reprod Biol 2022;22:100605. [PMID: 35078033 DOI: 10.1016/j.repbio.2022.100605] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Li S, Yang Y, Liu F, Song Q. Molecular Mechanism of miR-29b on Gestational Diabetes and Its Influence on Trophoblast Cell Function. j biomater tissue eng 2022;12:81-9. [DOI: 10.1166/jbt.2022.2871] [Reference Citation Analysis]
7 Yang X, Wu N. MicroRNAs and Exosomal microRNAs May Be Possible Targets to Investigate in Gestational Diabetes Mellitus. Diabetes Metab Syndr Obes 2022;15:321-30. [PMID: 35140490 DOI: 10.2147/DMSO.S330323] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
8 Chen T, Liu D. The Mystery of Exosomes in Gestational Diabetes Mellitus. Oxid Med Cell Longev 2022;2022:2169259. [PMID: 35720179 DOI: 10.1155/2022/2169259] [Reference Citation Analysis]
9 Liu Q, Wang M, Xu T, Liang W, Yang F. Significance of serum miR-29a in the occurrence and progression of diabetic nephropathy: A cross-sectional study. J Clin Lab Anal 2021;:e24210. [PMID: 34964177 DOI: 10.1002/jcla.24210] [Reference Citation Analysis]